Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07469384 · ClinicalTrials.gov registry record · NA
Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
A NA study of Schizo Affective Disorder and SCHIZOPHRENIA 1 (Disorder), sponsored by Nathan Kline Institute for Psychiatric Research.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07469384 is a NA study of Schizo Affective Disorder and SCHIZOPHRENIA 1 (Disorder) that is actively recruiting participants, run by Nathan Kline Institute for Psychiatric Research. The registered enrollment target is 120 participants, above the 68-participant average among 23 other Schizo Affective Disorder trials with a reported enrollment target (76% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07469384, a NA study of Schizo Affective Disorder and SCHIZOPHRENIA 1 (Disorder), is actively recruiting participants, sponsored by Nathan Kline Institute for Psychiatric Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the ability of transcranial direct current stimulation (tDCS) applied over the motion processing area of the brain (area MT) to improve face emotion recognition (FER) ability. tDCS is a type of non-invasive brain stimulation in which low level currents are applied over the scalp to influence underlying brain function. In schizophrenia, impaired ability to detect facial motion has been shown to contribute to impaired FER, which, in turn, leads to difficulties in social cognition and poor social outcome. The study will use both fMRI and EEG to measure brain function while participants view moving dot and dynamic face stimuli. Analyses will compare changes in fMRI and EEG activity in individuals receiving active vs. sham stimulation.
Conditions Studied
Interventions
- DEVICE Sham stimulation
- DEVICE transcranial direct current stimulation
Study Locations (1)
New York
- Nathan Kline Institute - Orangeburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-02-01 |
| Est. Completion | 2030-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07469384
The ClinicalTrials.gov registry entry for NCT07469384 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 68-participant average among 23 other Schizo Affective Disorder trials with a reported enrollment target (76% higher). The listed sponsor is Nathan Kline Institute for Psychiatric Research, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Schizo Affective Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sham stimulation is the first listed.
NCT07469384 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07469384 about?
NCT07469384 is a clinical study titled "Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways". This study investigates the ability of transcranial direct current stimulation (tDCS) applied over the motion processing area of the brain (area MT) to improve face emotion recognition (FER) ability. tDCS is a type of non-invasive brain stimulation in which low level currents are applied over the sc...
What is the current status of trial NCT07469384?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-02-01. Estimated completion is 2030-07.
What conditions does trial NCT07469384 study?
This clinical trial studies the following conditions: Schizo Affective Disorder, SCHIZOPHRENIA 1 (Disorder).
What interventions are being tested in trial NCT07469384?
The interventions under investigation include: Sham stimulation (DEVICE), transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT07469384?
This trial is sponsored by Nathan Kline Institute for Psychiatric Research, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07469384 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizo Affective Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Cognitive Training for Emotion Regulation in Psychotic Disorders
RECRUITING · NA
-
Visual Perception in Schizophrenia
RECRUITING · NA
-
iTBS to Enhance Social Cognition in People With Psychosis
RECRUITING · NA
-
Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia
RECRUITING · NA
-
Ketogenic Diet in People With Schizophrenia
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.